Where Are You on the Investor Confidence Curve?
How much you know about money and how confident you feel about it are two different things, and the gap between them shapes almost every financial decision you make.
Continue readingMarkets, equity compensation and planning, written for people who want the evidence rather than the hype. New articles about once a month.
How much you know about money and how confident you feel about it are two different things, and the gap between them shapes almost every financial decision you make.
Continue reading
The good news and the bad news
Continue reading
If you would never let a manuscript through review without checking the methods, you shouldn't let your financial plan through without checking them either.
Continue reading
"What is your favorite drink?" I asked a scientist friend. "It is a dirty martini," he replied, "the simplest possible formulation yet endlessly retested. Every bartender tries, in vain, to find a better ratio for it." ...
Continue reading
Recent discussions about what it would take for AI to succeed keep returning to one stubborn bottleneck: alignment. Even if compute scales, algorithms improve, and economic value is clear, systems can still fail by optim...
Continue reading
Are we all saving too much for a future we might not fully enjoy?
Continue reading
As we continually assess the evolving risks shaping portfolios and long-term planning, two interconnected areas warrant close attention: the structural pressures in the US Treasury market amid rising federal debt, and th...
Continue reading
“How does a financial advisor justify a 1-2% fee when I can buy an index fund for almost nothing?”
Continue reading
The fog of war and the fog of a bear market have more in common than most people realize. In both arenas, pressure reveals whether a strategy was ever real — or just a plan that felt good when stakes were low. As analyst...
Continue reading
Great‑power rivalry, economic fragmentation, and transnational instability have converged to create one of the most complex geopolitical environments in decades. More than a decade ago, Joseph S. Nye Jr. captured this em...
Continue reading
The U.S. Treasury market enters 2026 at a pivotal moment. Investors are weighing the effects of Federal Reserve rate cuts, moderating inflation, and persistent fiscal pressures that continue to shape long‑term yields. Th...
Continue reading
If you’re a scientist—or simply someone with an above‑average IQ—you’ve probably been told that intelligence is a major driver of success. And to some extent, that’s true. There is good news: research shows that higher I...
Continue reading
As 2025 winds down and the S&P 500 hovers in the 6,800–6,900 range, it’s hard not to look ahead and wonder what 2026 has in store. This year has been another strong one—AI-driven productivity gains, resilient earnings, a...
Continue reading
The legendary Woodstock for Capitalists took place on May 3 in Omaha, Nebraska, drawing nearly 20,000 attendees eager to hear Warren Buffett’s wisdom. Here are some of the most insightful moments I captured from the meet...
Continue reading
China’s monetary landscape is undergoing a dramatic shift. As of March 2025, the country’s M2 money supply—encompassing cash, checking deposits, and near-liquid assets like savings and time deposits—has surged to an asto...
Continue reading
The defense sector, long a cornerstone of global markets, is witnessing a striking divergence in 2025. European defense stocks are soaring, fueled by aggressive rearmament and a push for strategic autonomy, while U.S. de...
Continue reading
For years, I was like many researchers—dedicated, driven, and focused entirely on my work. My research was everything, and I believed my passion would carry me through. But amidst the long hours and relentless pursuit of...
Continue reading
Restricted Stock Units (RSUs) are a common part of compensation packages in the pharmaceutical industry, where companies like Pfizer, Amgen, or Gilead Sciences use them to attract and retain top talent. For employees wor...
Continue reading
In the pursuit of advancing human knowledge, scientists face numerous challenges that extend far beyond the lab bench. From securing funding to combating misinformation, these hurdles impact research outcomes and scienti...
Continue reading
Science is powered by a rich tapestry of personalities, each bringing unique strengths to the table. Having worked as a scientist for 14 years and now as a financial expert for the past 14 years, I’ve had the privilege o...
Continue reading
The role of a researcher has traditionally been viewed as offering bond-like Human Life Value for financial planning purposes. This perception stems from the steady, predictable income and job security typically associat...
Continue reading
Are you passionate about building wealth while contributing to groundbreaking medicines? After 10 years in drug discovery research and 15 years in financial planning for pharmaceutical scientists, I've distilled my insights...
Continue reading